ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PRM Proteome Sciences Plc

3.55
0.00 (0.00%)
Last Updated: 08:00:16
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.55 3.02 4.00 - 0.00 08:00:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 7.78M 1.33M 0.0045 7.89 10.48M
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 3.55p. Over the last year, Proteome Sciences shares have traded in a share price range of 2.97p to 8.50p.

Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £10.48 million. Proteome Sciences has a price to earnings ratio (PE ratio) of 7.89.

Proteome Sciences Share Discussion Threads

Showing 157501 to 157525 of 157525 messages
Chat Pages: 6301  6300  6299  6298  6297  6296  6295  6294  6293  6292  6291  6290  Older
DateSubjectAuthorDiscuss
14/5/2024
07:30
Huge medical news on Breakfast TV this morning involving stroke and ADI must have missed the mention of Prm front and centre.
canaletto
13/5/2024
15:48
Ah remember the days of CK1 Delta - alzheimers cure - if you are a mouse you have nothing to worry about any more.

Remember the doctor who had never seen anything like proteome in terms of predicting cancer pathways etc.

Sadly no more pie in the sky stuff.


Would be nice to see their US research lab winning a load of business and taking them into long term profitability, if they could get up to USD 20m a year they may even pay off the CJP loan.

octopus100
12/5/2024
19:25
#92913 You miss the bit where the Chairman tells attendees what pub he's visiting after the AGM, so drummimg up the attendees to buy his Gin & Tonic!
dominiccummings
12/5/2024
16:02
We will see,maybe just maybe they will pull something out of the hat.
peverill
12/5/2024
15:42
I am not so sure peverill. I live in hope!
goatherd
12/5/2024
15:19
The usual spiel,regurgitate some previous presentation with a new spin on it,you know the score Richard,you've done plenty of it and yet here we are,no further forward.
peverill
12/5/2024
15:04
And what is she going to say in the webcast presentation?
goatherd
12/5/2024
14:50
base7,

Yes, I share some of your thoughts on that. BUT we have been there before.

It could just be that the CEO got out of bed one morning and thought "Oh, its a long time since I made a presentation. Perhaps I should do one to show the shareholders I am earning my keep."

I do prefer your version, but I fear they are both possible versions; and, of course, there are many more.

goatherd
12/5/2024
12:53
AGM coming up,should last all of 20 minutes and see you all next year.And thanks for the steady wage and your patience.
peverill
11/5/2024
16:57
Proteome Sciences AGM is next Thursday at midday. This is broadcast live on the 'investormeetcompany' website.
pools2
11/5/2024
16:16
Interesting to note that there will be an Investor Meets next Thursday @ midday.These presentations usually take place within a day or two of results or following significant contract news.It will be 3 weeks after the recent RNS regarding the 500k contract, which I would not have thought would warrant a CEO presentation -so what might our CEO have to tell us next Thursday which we dont already know following results last month & the recent contract award ? The optimist in me hopes for an RNS ahead of Thursdays presentation which will explain clearly why our CEO considers it necessary to make a presentation.
base7
10/5/2024
12:59
One for those with long memories here - was it 2002 everyone starting getting excited about their biomarkers for this?
bluemango
08/5/2024
11:37
wasjobber?
monte1
08/5/2024
11:19
SINGLE CELL PROTEOMICS (SCP)

Over 1000 cells per day with TMTpro 32-plex

pools2
04/5/2024
05:56
As you were!!
peverill
01/5/2024
08:15
Presumably the other secondary avatar wasjobber is being prepped to verify that to be the case as we 'speak'?
barry evans
01/5/2024
07:30
I'm not sure investors fully appreciate the significance of Proteome Sciences new 32-plex TMTpro reagents, which will probably be officially announced by Thermo at this years ASMS in Anaheim early next month. It's not just a near doubling of the current 18-plex TMTpro reagent, but also a massive improvement of Thermo's mass spec capabilities, which will leave their competitors far behind them in performance and sample throughput.

One users perspective :-

www.proteomicsnews.blogspot.com/2024/04/is-tof-killing-technology-on-horizon.html

The new 32-plex TMTpro reagents will have big consequences for the mass spec proteomics market and its competitors.

pools2
28/4/2024
17:18
Thermo Fisher Scientific Reports First Quarter 2024 Results24th April 24Source: Business WireThermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024.First Quarter 2024 HighlightsFirst quarter revenue was $10.34 billion.First quarter GAAP diluted earnings per share (EPS) increased 4% to $3.46.First quarter adjusted EPS increased 2% to $5.11.
goggin
26/4/2024
21:41
10p-ish...Ha! i suspect that gave The Diggles, the giggles. ~40Mln buyout after 30 years-ish.......The mind boggles.
cdlaney
26/4/2024
18:24
Well done PRM. Not a holder but wish them well
mashman
26/4/2024
11:37
Oh look, more AZ pTau217 FDA designated blood tests, theyre like buses except prm dont have one


5:10 PM · Apr 18, 2024
Quanterix
@QuanterixSimoa
Exciting news in Alzheimer's care! Quanterix's Simoa® p-Tau 217 blood test has earned Breakthrough Device designation from the US FDA as a diagnostic aid for #Alzheimers. This pivotal moment in AD research offers new hope for #diagnosis and treatment.


3:22 PM · Apr 24, 2024
ADxHealth
@adxhealth
WellMind p-Tau217 is a blood test used to detect levels of Tau217, which has been shown to be elevated in Alzheimer's Disease patients and increase of the course of the disease. Launching Soon!

elpirata
26/4/2024
11:37
Not on the radar- yet, needs 2 - 3 more wins
goggin
26/4/2024
11:28
3k of shares bought,tells you all you need to know.
peverill
26/4/2024
10:20
It looks like Proteome Sciences share price is turning to an uptrend. The eight month downtrend has just been broken to the upside. Richard Dennis hints at further big contracts to come this year.

Of course, this is all peanuts compared to the Alzheimer's disease, cancer and stroke IP that will lead to a significantly increased share price.

STRONG BUY

wasjobber
26/4/2024
09:29
Yes agreed, they have been a basket case but have survived. As many said, I don't know how they screwed up during covid but here we are. Where's there's life, anything is possible, just look at Trump
goggin
Chat Pages: 6301  6300  6299  6298  6297  6296  6295  6294  6293  6292  6291  6290  Older

Your Recent History

Delayed Upgrade Clock